Welcome to Nofinity

In this episode of the Huberman Lab Podcast, Andrew Huberman speaks with Dr. Ralph Adolphs, a world-leading expert on the neurobiology of emotions. The discussion debunks myths, explains the scientific basis of emotions, and offers practical tools for emotion regulation.

• Dr. Adolphs defines emotions as functional states that control behavior in response to specific environmental challenges. They are more flexible than reflexes but less flexible than goal-directed behavior.
• Key features of emotions include:
  • Priority: Emotions can interrupt ongoing behavior (e.g., fleeing from a bear).
  • Valence: The basic dimension of approach or avoidance (pleasant vs. unpleasant).
  • Scalability: The intensity of an emotion can be graded (e.g., from worry to panic).
  • Temporal Persistence: Emotional states last over time, independent of explicit memory (as shown in a study with amnesia patients).

• According to functional criteria, animals like dogs and cats clearly have emotions.
• Artificial Intelligence (AI), such as large language models, could also possess functional emotions, a fascinating but also unsettling idea.

• A central point is the separation of emotion from conscious feeling. Dr. Adolphs argues for studying emotions independently of consciousness to advance science, similar to how vision or memory are studied.

• Emotion regulation is a critical human skill. The ability to observe and regulate one's own emotions is trainable.
• Emotional Granularity: The ability to finely distinguish one's own emotions is helpful but not necessarily tied to language.

• Cognitive Reappraisal: A strategy that must be trained to avoid spiraling thoughts. The earlier you stop the process, the better.
• Ice Bathing: Dr. Adolphs reports a personal experiment: Through regular ice bathing, his autonomic emotional response to stressors (like being honked at in traffic) became automatically downregulated. He sees this as autonomic training that makes emotion regulation "smooth and effortless."
• Ultramarathon: Training for a 100-mile race teaches nonlinear optimism. The experience of recovering from a low point strengthens resilience.

• The widespread belief that emotions can be reliably read from standardized facial expressions (like those of Paul Ekman) is debunked. These expressions are posed, and the tests are too simple (multiple choice).
• In real life, emotions are dynamic and context-dependent. We recognize them more by changes in behavior or communication than by a single photograph.

• The question of whether emotions have specific "body maps" (e.g., sadness in the heart) is not yet definitively answered. The body maps shown in popular graphics are based on people's concepts, not on measured physiological data.
• The insula is a brain region crucial for the conscious perception of body states (e.g., heart palpitations) and thus for the feeling of emotions.

• There is no single form of emotional intelligence. Those who succeed have a variety of strategies and can flexibly adapt them to the context.
• Dr. Adolphs' lab studies autism (as a spectrum) and finds that people with autistic traits pay less attention to social cues like faces and are more easily distracted. This is a stable personality trait.

• Dr. Adolphs shares personal experiences with an illness and emphasizes how it led to greater gratitude and awe.
• He recommends taking time for oneself (e.g., meditation, running) to train control over one's thoughts and emotions and to improve the ability to task-switch.

This video demonstrates how to build an AI trading bot that mimics Warren Buffett's investment strategy, using the open-source "AI Hedge Fund" project on GitHub. The bot leverages Claude (Fable 5.1) and real-time financial data (e.g., from Financial Datasets) to analyze stocks and execute trades.

Key Steps & Results:

• Stock Analysis: The AI Buffett rated Apple as neutral (60% confidence) and Nvidia cautiously (due to margin concerns). Coca-Cola received the highest confidence (68%).
• Portfolio Construction: With a simulated $100,000 fund, the bot selected 24 stocks from the S&P 500 top 100. Top holding: Microsoft; smallest: IBM. Only 3% cash.
• Backtest (Sept. 2024 to present): The AI Buffett outperformed the S&P 500 with a return of 39.2% vs. 34.8% and a lower max drawdown (5.8% vs. 8%). Best performer: Alphabet (+114%); worst: Accenture (-$2,000).
• Automation: The bot can be connected to an Alpaca paper trading account via API for automatic order execution. Persistent operation on a VPS is supported.

Conclusion:

The simulation suggests an AI model based on Buffett's approach can beat the market — at least in backtesting. However, the creator warns against entrusting real savings to such a bot. The project is intended as an experiment and learning tool.

Summary follows...

The 2 Amino Acids That Restore Muscle Strength & Burn 78% More Fat

This summary analyzes a study on GlyNAC (Glycine + N-Acetylcysteine) and its effects on mitochondrial health, muscle strength, and fat metabolism in older adults.

• Mitochondrial Dysfunction: Aging muscle cells lose the ability to efficiently burn fatty acids.
• Glutathione Deficiency: Intracellular glutathione, the cell's master antioxidant, is reduced by up to 70% in older adults.
• Root Cause: Two rate-limiting building blocks – glycine and cysteine – are equally depleted with age.

• Mechanism: The cell needs both amino acids to produce glutathione. Glycine and NAC provide the missing components.
• Study Design: 24 overweight older adults (61-80 years) received 100 mg/kg glycine + 100 mg/kg NAC daily (approximately 9 g per amino acid for a 90 kg person) for 16 weeks.

• Glutathione Increase: +225% in red blood cells, +164% in muscle biopsies – reaching levels of young adults.
• Fat Oxidation: +78% increase.
• Muscle Strength:
  • Gait Speed: +0.21 m/s (matching young adult levels)
  • Grip Strength: +4.4 kg (dominant hand)
  • Chair Rise Test: -6.8 seconds (better leg power)
• No Muscle Gain: Lean mass remained unchanged. Strength gains resulted from improved mitochondrial efficiency.

• Anti-Inflammatory: Interleukin-6 decreased by 78%, TNF-alpha by 54%, protective interleukin-10 nearly doubled.
• Insulin Resistance: HOMA-IR decreased by 64%.
• Oxidative Stress: DNA damage markers dropped by 73%.
• Blood Pressure: Systolic decreased from 132 to 124 mmHg.

• High Dosage: The study used very high doses (18 g of amino acids daily). Lower doses have not been tested.
• No Sustained Effect: After stopping GlyNAC, glutathione levels and strength gains returned to baseline.
• Lifespan Extension: The often-cited 24% lifespan increase comes from a mouse study, not human data.

GlyNAC addresses a core cause of age-related strength and energy loss: glutathione deficiency. The results are promising but require medical supervision, especially at high doses and regarding potential drug interactions.

• A 49-year-old sets the ambitious goal to dunk a basketball – a symbol of youthful athleticism and vitality.
• He trains with a professional coach who works with NBA players and has been at it for nearly 3 months.

• Instead of abstract metrics like VO2max (which he previously pushed to elite 18-year-old levels), he now focuses on a visible, relatable target.
• A dunk resonates with people: „The best biomarker I could ever achieve.“

• Phase 1 (first 2 months): Build a strong physiological base – especially tendon health and stiffness (tendons adapt in 8–12 weeks, muscles in 3–4).
• Phase 2 (from month 3): Add strength (for force production) and later speed (rate of force development).
• Current vertical jump measurement: 23.9 inches (approx. 60.7 cm) – baseline.

• After 3 months he feels clear gains and more trust in his body.
• The coach estimates an 80–85% success probability – aided by lean physique, good nutrition and sleep.
• Key: precise execution of drills (e.g., knees over toes in squats, bouncy movements).

„It‘s not about stopping the negative, it‘s about doing the positive.“ – The journey to a dunk is a statement against age limits.

• Clarity Act Fails: The first major US crypto regulation bill died in the Senate (49:50, 10 votes short). Coinbase stock fell 8%, Circle ~10%. Bitcoin ignored it.
• Fed Rate Hike: The US Federal Reserve raised rates by 25 basis points (first since 2023). The 10-year Treasury yield spiked above 5%, the Bank of Japan hiked to a 31-year high. Bitcoin still rose.
• AI Sector Weakens: Anthropic's CEO warned about runaway AI progress. Sam Altman and Elon Musk agreed. The semiconductor index dropped over 5%; Nvidia, ASML, SoftBank all fell. Crypto remained unfazed.

• 84% of liquidations were shorts ($843M of $1B total).
• In a single hour, over $300M was liquidated, 97% of it shorts.
• Between 126,000 and 135,000 accounts were closed.
• One wallet lost 375 BTC (~$32.5M) in four sequential liquidations over 14 hours.
• Mechanics: Forced buying from short liquidations pushes price higher → triggers next layer of shorts → cascade.

• Clarity Act irrelevant for markets: A failed bill changes nothing about Bitcoin's functionality (blocks, trades, custody). Crypto grew to over $1 trillion without US regulation.
• Institutions keep buying:
  • Strategy (MicroStrategy) bought 950 BTC for $75M right in the worst news week.
  • US spot Bitcoin ETFs lost $450M on voting day, but regained $433M just three sessions later.
  • Morgan Stanley's Bitcoin ETF logged 20 consecutive days of net inflows.

• China ban 2021: >50% of global hashrate went offline → Bitcoin rose from $29K to new ATH in 4 months.
• FTX collapse Nov 2022: Low of $15,400 – the absolute bottom.
• US banking crisis March 2023: Three banks failed, USDC depegged → Bitcoin rallied 40%.
• Inverse: Coinbase IPO April 2021 (peak) and ETF approval January 2024 (price fell from 49K to 38K) – good news marked tops.

Bitcoin is not a market that only rises on good news. The current rally through three parallel shocks shows: A strong holder base and institutional demand drive price independently of politics and macro. Future headlines may be just as grim – but crypto has proven itself through years of uncertainty and hostility. The question: Higher from here, or a bull trap?

Kaspi.kz (NASDAQ: KSPI) is a super app from Kazakhstan that covers nearly the entire financial and daily life of the country. The stock offers a dividend yield of almost 9 %, a P/E ratio of about 7, and growth of around 17 % – for the analyst, it's hard to find much wrong.

• Monopoly position: 85 % of payment processing and 70 % market share in consumer commerce in Kazakhstan.
• Government integration: Deep cooperation with the government and central bank – considered “too big to fail.” After a short-seller report (Culper Research), regulators immediately defended the company.
• Super app: Used for healthcare, government services, and banking – practically the entire population depends on it.
• Monopoly with political backing: This only works in Kazakhstan, but there it is a legal money-printing machine.

• Acquisition of Turkish e-commerce leader Hepsiburada for $1.1 billion.
• Acquisition of a banking license (Rabobank license) and planned capital injection of $300 million.
• Expansion of a “Buy Now, Pay Later” business and integration of fintech solutions into the Turkish platform.
• If Turkish profitability even approaches Kazakh levels, this could become a major winner.

• Net income is growing, stable net margin of around 27 %.
• E-commerce growth and payment business are strong thanks to the monopoly position.
• Non-performing loans (NPL): About 6–7 % and slightly rising – worth watching, but cushioned by high interest rates (15 % central bank rate).
• Balance sheet: $15 billion in customer loans, $17 billion in customer deposits – typical bank risks, but with fintech margins.

• Kazakhstan risk: Political connections, corruption allegations, possible rumors about bank stability.
• Dependence on the state: If political support changes, the business model would be in danger.
• Currency risk: Tenge fluctuations, but growth remains strong when measured in dollars.
• Bank risk: As a financial company, always vulnerable to loss of confidence and potential bank runs.

• P/E of 8 with 15 % growth and an 8–9 % dividend yield provide a margin of safety.
• Tencent as an investor and the “Silk Belt and Road” connection to China are additional strategic pluses.
• Founders own 66 % of the capital – without them the construct would not work, which creates resilience.
• The analyst is considering adding the stock to his diversified portfolio, although he considers the environment risky. “Hard to find much wrong” – but it remains an engaged emerging-market investment.